SEC Form 3 · accession 0001209191-18-038845
Kezar Life Sciences, Inc. · KZR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Franklin Fowler
Officer — CEO · Director
Period of report
Jun 20, 2018
Accepted (ET)
Jun 20, 2018 · 5:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645666
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 292,704 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.90 | holding | — | — | — | — | Sep 9, 2025 | Common Stock | 156,421 | — | D |
| Employee Stock Option (Right to Buy)F2 | $1.41 | holding | — | — | — | — | Sep 14, 2026 | Common Stock | 48,932 | — | D |
| Employee Stock Option (Right to Buy)F3 | $2.37 | holding | — | — | — | — | Oct 9, 2027 | Common Stock | 177,935 | — | D |
| Employee Stock Option (Right to Buy)F4 | $2.37 | holding | — | — | — | — | Jan 6, 2028 | Common Stock | 88,967 | — | D |
| Employee Stock Option (Right to Buy)F5 | $5.91 | holding | — | — | — | — | Apr 15, 2028 | Common Stock | 133,451 | — | D |
Explanation of responses
- F1Twenty-five percent (25%) of the shares subject to the option shall vest on June 11, 2016, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the last day of the month, subject to the Reporting Person continuing to provide service through each such date.
- F2Twenty-five percent (25%) of the shares subject to the option shall vest on June 11, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the last day of the month, subject to the Reporting Person continuing to provide service through each such date.
- F3Twenty-five percent (25%) of the shares subject to the option shall vest on July 21, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the last day of the month, subject to Reporting Person continuing to provide service through each such date.
- F4One forty-eighth (1/48th) of the shares shall vest on a monthly basis, on the last day of the month, commencing on the January 1, 2018, subject to the Reporting Person continuing to provide service through each such date.
- F5Twenty-five percent (25%) of the shares subject to the option shall vest on January 1, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the last day of the month, subject to the Reporting Person continuing to provide service through each such date.